An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis
S. Karanika, J. Gordy, P. Neupane…·P. Karakousis
This paper develops a DNA vaccine targeting dendritic cells that enhances isoniazid efficacy against tuberculosis by inducing strong immune responses and reducing Mtb burden.